BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19875475)

  • 1. Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy.
    Surlan-Popovic K; Bisdas S; Rumboldt Z; Koh TS; Strojan P
    AJNR Am J Neuroradiol; 2010 Mar; 31(3):570-5. PubMed ID: 19875475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements.
    Bisdas S; Rumboldt Z; Surlan-Popovic K; Baghi M; Koh TS; Vogl TJ; Mack MG
    AJNR Am J Neuroradiol; 2010 Mar; 31(3):576-81. PubMed ID: 19875471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.
    Rana L; Sharma S; Sood S; Singh B; Gupta MK; Minhas RS; Jhobta A; Bhatia V; Venkat B
    Eur J Radiol Open; 2015; 2():46-54. PubMed ID: 26937435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment perfusion CT and CT volumetry in squamous cell carcinoma of the head and neck region.
    Popovic KS; Lukic S; Popovic P
    J BUON; 2014; 19(4):937-43. PubMed ID: 25536599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer.
    Curvo-Semedo L; Portilha MA; Ruivo C; Borrego M; Leite JS; Caseiro-Alves F
    Acad Radiol; 2012 Feb; 19(2):203-13. PubMed ID: 22130088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion computed tomography in predicting treatment response of advanced esophageal squamous cell carcinomas.
    Li MH; Shang DP; Chen C; Xu L; Huang Y; Kong L; Yu JM
    Asian Pac J Cancer Prev; 2015; 16(2):797-802. PubMed ID: 25684528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements.
    Bisdas S; Rumboldt Z; Wagenblast J; Baghi M; Koh TS; Hambek M; Vogl TJ; Mack MG
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):793-9. PubMed ID: 19351906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer.
    Li XS; Fan HX; Zhu HX; Song YL; Zhou CW
    Eur Radiol; 2012 Mar; 22(3):617-24. PubMed ID: 21960157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?
    Zima A; Carlos R; Gandhi D; Case I; Teknos T; Mukherji SK
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):328-34. PubMed ID: 17297007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy.
    Truong MT; Saito N; Ozonoff A; Wang J; Lee R; Qureshi MM; Jalisi S; Sakai O
    AJNR Am J Neuroradiol; 2011 Aug; 32(7):1195-201. PubMed ID: 21757530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume.
    Petralia G; Preda L; Giugliano G; Jereczek-Fossa BA; Rocca A; D'Andrea G; Holalkere NS; Chiesa F; Bellomi M
    J Comput Assist Tomogr; 2009; 33(4):552-9. PubMed ID: 19638848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular permeability determined using multi-slice spiral CT perfusion can predict response to chemoradiotherapy in patients with advanced cervical squamous cell carcinoma
.
    Liu J; Fan H; Qiu GP
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):619-626. PubMed ID: 28291509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
    Nuyts S; Dirix P; Clement PM; Poorten VV; Delaere P; Schoenaers J; Hermans R; Van den Bogaert W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1088-95. PubMed ID: 18707823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion.
    Nyflot MJ; Kruser TJ; Traynor AM; Khuntia D; Yang DT; Hartig GK; McCulloch TM; Wiederholt PA; Gentry LR; Hoang T; Jeraj R; Harari PM
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):942-51. PubMed ID: 25659884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
    Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx.
    Loong HH; Winquist E; Waldron J; Chen EX; Kim J; Palma D; Read N; Razak AR; Diaz-Padilla I; Chan K; Bayley A; Hossain M; Wang L; Chin S; Siu LL; Hope A
    Eur J Cancer; 2014 Sep; 50(13):2263-70. PubMed ID: 24953566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy.
    Gandhi D; Chepeha DB; Miller T; Carlos RC; Bradford CR; Karamchandani R; Worden F; Eisbruch A; Teknos TN; Wolf GT; Mukherji SK
    AJNR Am J Neuroradiol; 2006 Jan; 27(1):101-6. PubMed ID: 16418366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.